Find more about:​

The Company

Who we are

Diaxxo AG, founded in 2020, is a spin-off of the Functional Materials Laboratory (FML) of ETH Zürich.

We envision a future where precise and reliable diagnostics can be accessed anywhere by anyone.
We believe that thanks to our Point-Of-Care PCR tests, doctors will be able to identify and fight diseases faster,
and experts will be able to perform much DNA analysis in a shorter time.

Our mission is to enable DNA analyses to be widely diffused and adopted by making them accurate, fast and affordable.

Quality

Quality is our priority. As your results are only as good as your detection technique.

Teamwork

Team work is our strenght and philosophy as it takes two flints to make a fire.

Passion

Passion is our driving force as nothing great can be accomplished without it.

Founders

It’s not about ideas. It’s about making ideas happen.

Dr. Michele Gregorini

Founder and CEO

A PhD spent building all sort of devices, in particular this pyramid-shaped PCR machine that will change the way DNA analyses are performed!

Prof. Wendelin Stark

Founder

Full Professor at ETH Zürich

Dr. Tobias Schindler

Biologist

Tobi has a long experience in DNA analysis gained in important institutions, especially in the field of infectious diseases.

Luca Montemartini

Biomedical Engineer

Luca brings our machines to life with the power of automation.

Team

The people that want to change the world with us.

Edgar Vela

Hardware Engineer

The hardware guru! Edgar finds solutions to any problem you can think of.

Viviane Gerber

Software Engineering

Everyone can code these days. Viviane, instead, writes beautiful poems of 1s and 0s.

Martin Privet

Mechanical Engineer

Fatih Eser

Software Engineer

Lorenzo

Lorenzo Trevisan

Software Engineer

Guglielmo Murari

Product Designer

Octavio Oliva

Graphic Designer

Advisors

“Many receive advice, only the wise profit from it”

Mr. Ernst Zollinger

Board Advisor

Former ThermoFisher, Prionics, Novartis

Prof. Dr. Med. Christian Breymann

Medical Advisor

Hirslanden Zürich

Dr. Stefan Meier

Operations Advisor

Former Concretum

Mr. Charles Tschaggeny

Technical Advisor

Former Biofire

Mr. Peter Wyser

Strategic Advisor

Former Roche

Sales

Mr. Deniz Kaya

Head of Global Sales

Devadas Thangavelloo

Director of Sales Asia & Pacific

Sadegh Merkani

Business Development Manager EMEA

Ask Information

Give us your contacts and we will write you back

    Stay up to date

    Follow us to stay up to date

    Covid Variants

    diaxxoPod (RUO)

    Description

    Our in-vitro diagnostic test cartridge based on rapid Polymerase Chain Reaction (PCR) amplification technology. This cartridge can reliably detect and distinguish the mutants from UK (20I/501Y.V1, B.1.1.7 – VOC-202012/01) as well as the South African mutation (B.1.351 lineage).

    The test cartridge is aimed to improve the public health situation by rapidly enabling the detection of variants of concern. The cartridge is designed for qualitative detection of variants of interest of the SARS-CoV-2 Viral RNA in saliva samples and it works in conjuction with diaxxoPCR.

    Specs

    • Fully preloaded and only require addition of purified sample
    • Results in approx. 30 minutes

    Workflow

    The test cartridges are sold with all the necessary reagents pre-loaded in the reaction wells. The use of the test cartridges is therefore extremely simple:

    • Apply the sample (viral RNA)
    • Apply water in the control wells and the cover fluid
    • Insert the cartrdige in diaxxoPCR, press a button, drink a coffee and check your results.

    Notes & Instructions

    • The cartridges are supplied in a vacuum-sealed bag in order to ensure a long shelf life at room temperature.
    • Detailed instructions about how to use the cartridges and the devices are provided

    SARS-CoV-2

    diaxxoPod

    Description

    This SARS-CoV-2 cartridge is based on the US Centers for Disease Control and Prevention (CDC) RT-PCR test for 2019-nCoV. The assay detects 2 parts of the N gene specific for Sars-CoV-2. In addition, an extraction control for Human RNAse P is also included. The cartridge is designed to work in combination with saliva samples and in conjuction with our diaxxoPCR.

    Specs

    • Functionally validated and confirmed template-free to cycle 45 by NTC testing
    •  Fully preloaded and only require addition of purified DNA/RNA
    • Results within 30 minutes

    Workflow

    The test cartridges are sold with all the necessary reagents pre-loaded in the reaction wells. The use of the test cartridges is therefore extremely simple:

    • Apply the sample (viral RNA)
    • Apply water in the control wells and the cover fluid
    • Insert the cartrdige in diaxxoPCR, press a button, drink a coffee and check your results.

    Notes & Instructions

    • The cartridges are supplied in a vacuum-sealed bag in order to ensure a long shelf life at room temperature.
    • Detailed instructions about how to use the cartridges and the devices are provided

    Cookies

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.